BackAntares Pharma Overview

Antares Pharma Other Assets

Track Antares Pharma's other assets ($1.2M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Assets
$1.20M
51.88% YoYΔ $-1.30M vs prior year quarter

Peer trimmed avg / median

Loading

Antares Pharma Other Assets History

Loading

Antares Pharma vs. peers: Other Assets Comparison

Loading

Antares Pharma Other Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Antares Pharma (ATRS) FAQ

As of the most recent data (March 2022), ATRS shows a other assets of $1.2M. That compares with $2.5M in the prior-year period — down 51.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ATRS's other assets is now $1.2M (was $2.5M) — a 51.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Antares Pharma is outperforming or lagging.

Tracking ATRS's other assets over time shows whether Antares Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $1.2M That compares with $2.5M in the prior-year period — down 51.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other assets page, Stockcircle has Antares Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other assets (currently $1.2M) with ownership activity and broader fundamentals.

Antares Pharma's other assets is $1.2M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.